MEDIFAST (MED)
(Delayed Data from NYSE)
$33.71 USD
+0.21 (0.63%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $33.71 0.00 (0.00%) 7:58 PM ET
5-Strong Sell of 5 5
A Value B Growth F Momentum B VGM
Medifast (MED) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$37.50 | $40.00 | $35.00 | 11.94% |
Price Target
Based on short-term price targets offered by two analysts, the average price target for Medifast comes to $37.50. The forecasts range from a low of $35.00 to a high of $40.00. The average price target represents an increase of 11.94% from the last closing price of $33.50.
Analyst Price Targets (2 )
Broker Rating
Medifast currently has an average brokerage recommendation (ABR) of 3.00 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by two brokerage firms. The current ABR compares to an ABR of 3.00 a month ago based on two recommendations.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 0 | 0 | 0 | 0 | 0 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 2 | 2 | 2 | 2 | 2 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
2/21/2024 | D.A. Davidson | Linda B Weiser | Hold | Hold |
10/13/2023 | Stephens | Jim Salera | Not Available | Hold |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 3.00 |
ABR (Last week) | 3.00 |
# of Recs in ABR | 2 |
Average Target Price | $37.50 |
LT Growth Rate | NA |
Industry | Food - Miscellaneous |
Industry Rank by ABR | 143 of 252 |
Current Quarter EPS Est: | 0.63 |